Frequent exacerbations of chronic obstructive pulmonary disease--a distinct phenotype?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Plasma Proteomics Study Between the Frequent Exacerbation and Infrequent Exacerbation Phenotypes of Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2023
   Article
2. The recent advances of phenotypes in acute exacerbations of COPD.International journal of chronic obstructive pulmonary disease · 2017
   Review
3. Time course of inflammation resolution in patients with frequent exacerbations of chronic obstructive pulmonary disease.Medical science monitor : international medical journal of experimental and clinical research · 2014
   Article
4. Is Acute Exacerbation of COPD (AECOPD) Related to Viral Infection Associated with Subsequent Mortality or Exacerbation Rate?The open respiratory medicine journal · 2014
   Article
5. Roflumilast inhibits lipopolysaccharide-induced tumor necrosis factor-α and chemokine production by human lung parenchyma.PloS one · 2013
   Article
6. Health effects of the Federal Bureau of Prisons tobacco ban.BMC pulmonary medicine · 2012
   Article
7. E pluribus plurima: multidimensional indices and clinical phenotypes in COPD.Respiratory research · 2011
   Article
8. Optimizing management of chronic obstructive pulmonary disease in the upcoming decade.International journal of chronic obstructive pulmonary disease · 2011
   Review
9. Bioinformatics-based identification of potential microRNA biomarkers in frequent and non-frequent exacerbators of COPD.International journal of chronic obstructive pulmonary disease
   Article

Corrections and comments

• Comment on
  Susceptibility to exacerbation in chronic obstructive pulmonary disease.2010

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as